VTV Therapeutics Inc. Class AVTVT
13F holders, Q2 2024 (June 30)19holders
5new positions
5sold out
1famous investor
$17.66avg. 13F price*
At the end of Q2 2024, 19 institutions reported holding VTV Therapeutics Inc. Class A (VTVT) in their 13F filings, unchanged from Q1 2024. 5 opened new positions and 5 sold out. The largest holders were Samsara Biocapital, LLC ($3.7M), Baker Bros. Advisors LP ($1.7M) and Vanguard Group Inc. ($434K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- VTV Therapeutics Inc. Class A
- CUSIP
- 918385204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $220K |
| Exits | 5 | $16K |
All 13F filers, Q1 2024 → Q2 2024: 15,242 shares bought and 752 shares sold, net +14,490 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| Samsara Biocapital, LLC | 0.76% | No change | 206,784 | $3.7M |
| Baker Bros. Advisors LP | 0.02% | No change | 97,314 | $1.7M |
| Vanguard Group Inc. | 0.00% | No change | 24,558 | $434K |
| Millennium Management | 0.00% | New | 12,256 | $216K |
| UBS Group AG | 0.00% | Add +186.9% | 4,180 | $74K |
| BlackRock Inc. | 0.00% | Add +1.7% | 1,097 | $19K |
| Morgan Stanley | 0.00% | No change | 840 | $15K |
| Planning Capital Management Corp | 0.01% | No change | 625 | $11K |
| Osaic Holdings, Inc. | 0.00% | Add +13.3% | 170 | $3K |
| Strengthening Families & Communities, LLC | 0.00% | New | 173 | $3K |
| Activest Wealth Management | 0.00% | New | 50 | $883 |
| Parallel Advisors, LLC | 0.00% | No change | 38 | $671 |
| Cornerstone Planning Group LLC | 0.00% | No change | 19 | $277 |
| Sunbelt Securities, Inc. | 0.00% | No change | 15 | $265 |
| BNP Paribas Financial Markets | 0.00% | No change | 9 | $159 |
| Bank of America Corp. | 0.00% | Reduce -89.5% | 8 | $141 |
| JPMorgan Chase & Co. | 0.00% | No change | 2 | $35 |
| Qube Research & Technologies Ltd | 0.00% | New | 1 | $18 |
| Triad Wealth Partners, LLC | 0.00% | New | 1 | $18 |
"% of holder's portfolio" is VTVT's weight in each manager's 13F, not the share of VTV Therapeutics Inc. Class A the manager owns.